JOHN W. SEDWICK, Senior District Judge.
At docket 14 plaintiff VMAS Solutions, LLC ("VMAS") filed a reply in support of its motion for a preliminary injunction. Attached to the reply is the supplemental declaration of Vicki Mayo ("Mayo") (including two exhibits); the declaration of Jeffrey P. Thennisch ("Thennisch") (including two exhibits); and the declaration of Marc C. Sanchez ("Sanchez") (including one exhibit). At docket 18 defendant MMJ Labs, LLC ("MMJ") moves to strike all of these attachments or, alternatively, for leave to file a sur-response,
"Where new evidence is presented in a reply, the district [court] should either not consider the new evidence, or not consider it without giving the other party the opportunity to respond."
In Mayo's initial declaration at docket 8-1, Mayo asserts that MMJ's claim of trademark infringement is causing VMAS to suffer irreparable harm, including a decline in web traffic to its fundraising page on Kickstarter.com and decline in sales.
The supplemental Mayo declaration is not new evidence because it is directly responsive to MMJ's opposition. The court will deny MMJ's motion with regard to this declaration.
Thennisch is an attorney who represents VMAS in connection with its trademark filings before the U.S. Patent & Trademark Office ("PTO"). Baxter's declaration states that the FDA, "over multiple telephone conversations, provided instructions and advice to MMJ Labs regarding the facility registration process in 2008, which led to the determination that because both cold packs and therapeutic massagers, the main components of the BUZZY device, did not need 510(k) approval, the BUZZY device was exempt from the FDA's premarket notification requirements."
The court finds that paragraphs eight through twelve of the Thennisch declaration are not new evidence because they are directly responsive to Baxter's declaration for the reasons stated in VMAS' opposition. The remainder of Thennisch's declaration, however, is new evidence because it is not responsive to MMJ's opposition. Paragraphs four through seven of the Thennisch declaration will be stricken.
Sanchez states that he is an attorney who specializes in regulatory matters involving the FDA, an adjunct professor at Northeastern University School of Law, and an FDA regulatory consultant. Sanchez's declaration includes his "observations and findings" regarding MMJ's opposition and Baxter's declaration.
The Sanchez declaration is directly responsive to evidence and arguments raised in MMJ's opposition. The court will deny MMJ's motion with regard to this declaration.
Based on the preceding discussion, the motion at docket 18 is granted in part and denied in part as follows. Paragraphs four through seven of the Declaration of Jeffrey P. Thennisch at docket 14-1 are stricken. In all other respects, the motion is denied.